[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Hôpital Universitaire Sahloul\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":61},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,40],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":12,"acronym":13,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":25,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":4},"100604298",false,"NCT07147699","Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients Presenting With Dyspnea","CARDIOSTORY","Inclusion Criteria:\n\n* • Age ≥ 18 years\n\n  * Recent onset dyspnea (less than 7 days)\n  * Informed consent obtained\n\nExclusion Criteria:\n\n* • Age inferior to 18 years,\n\n  * Severe comorbidity, hemodynamic compromise or immediate need for mechanical ventilation were exclusion criteria.\n  * Dyspnea clearly of traumatic or allergic origin","ALL","18 Years",{"count":18,"type":19},650,"ESTIMATED","OBSERVATIONAL","The CARDIOSTORY.TN study is a prospective observational study at Sahloul University Hospital (Sousse, Tunisia) evaluating the CardioStory device for distinguishing heart failure (HF) from other causes of acute dyspnea.\n\nBackground: Dyspnea is common in emergencies, and differentiating cardiac from non-cardiac causes is often delayed by the limits of echocardiography and BNP tests. CardioStory is a rapid (\\~2 minutes), non-invasive tool that measures cardiac filling pressure, a key HF marker.\n\nObjectives:\n\nPrimary: Assess CardioStory's diagnostic accuracy.\n\nSecondary: Compare it with echocardiography and NT-proBNP, evaluate ease of use, and measure time to diagnosis.\n\nMethods:\n\nAdults (≥18) with acute dyspnea (\\\u003C7 days) included; unstable or traumatic\u002Fallergic cases excluded.\n\nCardioStory results will be compared to standard diagnostics.\n\nSample size: 850 patients over 12 months.\n\nOutcome: If accurate, CardioStory could be a fast, practical diagnostic tool for emergency settings.",[23,24],"Dyspnea","Heart Failure Acute",[26,27],"dyspnea","acute heart failure","NOT_YET_RECRUITING","2025-08-28",{"date":31,"type":32},"2025-08-29","ACTUAL",{"date":34,"type":19},"2025-09-01",{"date":36,"type":19},"2026-12-01",{"name":38,"class":39},"Hôpital Universitaire Sahloul","OTHER",{"id":41,"slug":4,"hasResults":10,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":47,"conditions":48,"keywords":4,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},"100599806","NCT07089277","External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population","Inclusion Criteria:\n\n* Adult patients (≥18 years) presenting with non-traumatic upper gastrointestinal bleeding\n\nExclusion Criteria:\n\n* patients under 18 years of age.\n\nDiagnosis of external hemorrhoids with mucosal lesions.\n\nPatients who do not consent, are lost to follow-up, or have incomplete data.",{"count":46,"type":19},250,"This study aims to externally validate the Glasgow-Blatchford Score (GBS) in a Tunisian population presenting with non-traumatic upper gastrointestinal bleeding. Despite advances in endoscopic management, early risk stratification remains essential to guide clinical decision-making. In Tunisia, the routine hospitalization of all patients for observation presents a challenge, highlighting the need for reliable prognostic tools.\n\nThe study is designed as a multicenter, descriptive, and analytical investigation across several emergency departments. Adult patients (≥16 years) will be included, with follow-up conducted at 30 days to assess for adverse outcomes including rebleeding, the need for hemostasis, complications, and mortality.\n\nClinical and epidemiological data will be collected using a standardized form. Statistical analysis will evaluate the predictive performance of the GBS, focusing on sensitivity, specificity, and predictive values for 30-day outcomes.\n\nThe results are expected to determine whether GBS is a valid and useful tool for risk assessment in the Tunisian context, potentially aiding in more efficient and targeted patient management.",[49,50],"Upper Gastrointestinal Bleeding (UGIB)","Glasgow-Blatchford Score","RECRUITING","2025-07-21",{"date":54,"type":32},"2025-07-28",{"date":56,"type":32},"2024-01-01",{"date":58,"type":19},"2025-12-30",{"name":38,"class":39},1,""]